{"id":"tp-60670","type":"article-newspaper","title":"Bristol Myers Squibb Says KarXT Improved Alzheimer’s Psychosis Scores","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/60670","datePublished":"2026-11-18T17:22:48.000Z","dateModified":"2026-11-18T17:22:48.000Z","language":"en","abstract":"The two Phase 3 trials found gains in hallucination and delusion scores, and the xanomeline and trospium chloride treatment was well tolerated.","section":"Business","references":[]}